/
Where Are We Going? Where Are We Going?

Where Are We Going? - PowerPoint Presentation

tatiana-dople
tatiana-dople . @tatiana-dople
Follow
367 views
Uploaded On 2015-10-12

Where Are We Going? - PPT Presentation

William Frank Barker LPC MAC Diane Diver LMSW CAC II The Perfect Storm The Field Key Forces WORKFORCE Healthcare Healthcare 28 Billion spent in 2010 to treat addiction which affects 40 million people ID: 157949

addiction healthcare trends treatment healthcare addiction treatment trends clinical substance billion behavioral people drug therapy abuse buprenorphine 2000 definition

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Where Are We Going?" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Where Are We Going?

William Frank Barker, LPC, MAC

Diane Diver, LMSW, CAC IISlide2

The Perfect StormSlide3

The FieldSlide4

Key Forces

WORKFORCESlide5

HealthcareSlide6

Healthcare

$ 28 Billion spent in 2010 to treat addiction which affects 40 million people

Versus

$107 Billion to treat heart disease which affects 27 million peopleSlide7

Relapse Rates Are Similar for Drug Addiction

& Other Chronic Illnesses

100

Type I

Diabetes

Drug

Addiction

0

10

20

30

40

50

60

70

80

90

Hypertension

Asthma

40 to 60%

30 to 50%

50 to 70%

50 to 70%

Percent of Patients Who Relapse

McLellan et al., JAMA, 2000.

HealthcareSlide8

Healthcare

ParitySlide9

Healthcare

Estimated U.S. Economic Cost to Society Due to Substance Abuse and Addiction

Illegal Drugs - $181 billion/year

Alcohol - $185 billion/year

Tobacco - $158 billion/year

Total - $524 billion/year

Source: Surgeon General’s Report, 2004; ONCP, 2004; Harwood, 2000.

arwood

, 2000. Surgeon General’s Report, 2004; ONDCP, 2004; Harwood, 2000. Slide10

Healthcare

How Its FundedSlide11

HealthcareSlide12

Healthcare

More people with 3

rd

party insurance

Shifts cost and focus: deductibles, reimbursement rates, outcome orientation, primary care physicianSlide13

Healthcare

Shift from management and administration of block grants to focus on “best practices,” grants, and outcome measurements.Slide14

HealthcareSlide15

HealthcareSlide16

HealthcareSlide17

HealthcareSlide18

HealthcareSlide19

Healthcare

2 Million people in US dependent/abuse opioids

18,582 Physicians are certified to prescribe buprenorphine.

9% of SA facilities are Opioid Treatment Programs (OTP) in 2011

Individuals receiving buprenorphine prescriptions in 2010 was 800,000 with only 5% coming from treatment programs

Emergency department visits involving buprenorphine increased from 3,161 in 2005 to 30,135 visits in 2010 as availability of the drug increased

.

Source: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (April 23, 2013).

The N-SSATS Report: Trends in the Use of Methadone and Buprenorphine at Substance Abuse Treatment Facilities: 2003 to 2011.

Rockville, MD.Slide20

Healthcare/Medical

Source: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (January 29, 2013).

The DAWN Report: Emergency Department Visits Involving Buprenorphine.

Rockville, MD.Slide21

Clinical TrendsSlide22

NIDA’s Principles of Treatment

No single treatment is appropriate for all individuals.

Treatment needs to be readily available.

Treatment must attend to multiple needs of the individual, not just drug use.

Multiple courses of treatment may be required for success.

Remaining in treatment for an adequate period of time is critical for treatment effectiveness.

Clinical TrendsSlide23

Clinical Trends

NIDA’s Principles of Treatment

Behavioral

Therapies:

Cognitive Behavioral

Therapy

Contingency Management Interventions/Motivational

Incentives

Community Reinforcement Approach Plus Vouchers

Motivational Enhancement Therapy

The Matrix Model12-Step Facilitation TherapyFamily Behavior TherapyBehavioral Therapies Slide24

Clinical Trends

“You can’t do cognitive therapy from a manual any more than you can do surgery from a manual.”

-Aaron T. Beck, New York TimesSlide25

Clinical Trends

1900s “Being on the wagon”

1930s “Not drinking alcohol”

1980 Sober is being totally chemically free

1990-2000 Relapse is a part of recoverySlide26

Clinical Trends

Audrey

Kishline

2000 Evidence based practices

Moderate drinking

Fewer drinking daysSlide27

ASAM Definition of Addiction

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors.Slide28

ASAM Definition of Addiction

Addiction is characterized by the inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one’s behaviors and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or death.Slide29

What is different about this definition?

The focus in the past has been generally on substances associated with addiction.

The new definition clarifies that addiction isn't about drugs, it’s about brains.

It is

not

the substance or the quantity or frequency of use that makes them an addict. Addiction is about what happens in the reward circuitry of the brain when exposed to a rewarding substance or behavior.Slide30

Clinical Trends

More Severe

Less Severe

The Acute Model Vs. ASAM Levels of CareSlide31

Clinical TrendsSlide32

Concerns About DSM-5 Changes

Would significantly increase the number of people being diagnosed with addiction.

The APA has not allowed enough discussion regarding these changes (secondary gain).

It could create false epidemics and

medicalication

of everyday behavior.

Possible boundary issues between DSM panel members and the pharmaceutical companies.Slide33

Public PerceptionSlide34

Clinical Trends

ACCOUNTABILITY COURTSSlide35

Clinical Trends

USE OF TECHNOLOGYSlide36

Implications for Clinicians

WORKFORCE

Peer Recovery Supports

Highly

TrainedSlide37

CONCLUSIONS

Medication Assisted Treatment

Physician Office/Counselor Embedded Treatment

Technology becomes a major tool

Increased qualifications for workforce

Serve More people

Prison/Drug courts may become converted to one payer

Related Contents


Next Show more